Press release

Change at the top of the Segment Advanced Therapies at Siemens Healthineers

Published on June 13, 2018
<p>On July 1, 2018, Michel Therin (56) will take over as Head of the Advanced Therapies business segment at Siemens Healthineers. The current head Heinrich Kolem (62) will begin his retirement on August 1, 2018.</p><p>Since 2005, Michel Therin has held various senior positions for development and strategy at Medtronic's Minimally Invasive Therapies Group. In his last post as Global Vice President and General Manager, he was responsible for the company's global business in minimally invasive therapies in general surgery. Michel Therin gained his doctor's degree in Biomedical Engineering in France at the Paris XIII University.</p><p>"In Heinrich Kolem, a senior manager is retiring who has had a major influence on the business development of Siemens Healthineers for almost 30 years. Under his leadership, the magnetic resonance imaging business has become the global market leader. In the course of his many years of local management, he has given decisive impetus to our U.S. business and subsequently driven forward consistently the development of our growing Advanced Therapies business. Heinrich Kolem is a model of integrity with a passion for medical innovation and unconditional customer focus. I would like to thank Heinrich Kolem most sincerely for his contribution to the success of our company and wish him all the best for the future," said Bernd Montag, CEO of Siemens Healthineers.</p><p>"With his long years of experience in minimally invasive therapy Michel Therin is an outstanding successor. He will use his expertise to advance the development of innovative technologies that promise both clinical and economic success. This will help our customers to integrate imaging information even better into their decision-making processes for determining bespoke treatment and to achieve better results for their patients," Bernd Montag added.</p><p>Siemens Healthineers' business activities are divided into three segments: Imaging, Laboratory Diagnostics and Advanced Therapies. With its Advanced Therapies segment, Siemens Healthineers is a leading global provider of highly integrated products as well as of solutions and services used by healthcare providers for therapy in various clinical areas. The products from the Advanced Therapies segment enable minimally invasive treatment through the use of high-quality imaging before and during medical procedures. In the last few years, these procedures have experienced growth in the areas of cardiology, interventional radiology, surgery and radio-oncology. </p><p><a href="/press/media-gallery" class="">Link to the related press pictures</a><br></p>

Siemens Healthineers

Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2017, which ended on September 30, 2017, Siemens Healthineers generated revenue of €13.8 billion and profit of €2.5 billion and has about 48,000 employees worldwide.